Travere Therapeutics Inc

TVTXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$60.57

Today

+1.3%

YTD

+58.8%

About

Travere Therapeutics Inc is at the cutting edge of bio-pharmaceuticals, designing innovative solutions for rare diseases. The firm operates on a global scale. Part of the competitive pharmaceuticals and biotechnology sector, Travere Therapeutics develops innovative therapies. It strives to tackle rare diseases inadequately addressed by the current healthcare system. Travere Therapeutics is currently working on therapies for focal segmental glomerulosclerosis, classical homocystinuria and Alagille syndrome. It has recently got FDA accelerated approval of a therapy for IgA nephropathy. Diversify your virtual portfolio by following TVTX shares on eToro.

Price chart

Closing price history for TVTX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-105.82

P/S (TTM)9.70

P/B (TTM)52.97

Market cap$5.26B

Cap tierMid-cap

Industry avg P/E-43.36

Profitability

Gross margin84.94%

EBIT margin-10.64%

Net margin-28.78%

ROE-69.38%

ROA-8.27%

Earnings & Revenue

Revenue (TTM)$536.20M

Revenue growth (1Y)+96.0%

EPS (TTM)-$0.53

Free cash flow$39.61M

Total debt$327.66M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.47

Employees497

Next earnings29 Oct '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.